Mounjaro vs Wegovy: Which Weight Loss Treatment Is Right for You? (2025 Guide)
Published on Jan 22, 2026
A Comprehensive Comparison of Leading Weight Loss Medications Introduction:In 2025, two revolutionary weight loss medications are leading the UK market: Mounjaro (tirzepatide) and Wegovy (semaglutide). Let's break down their differences to help you make an informed decision.
Quick Comparison Table:
Mounjaro:
• Active ingredient: Tirzepatide
• Weekly injection
• £149/month
• Average weight loss: 15-20% of body weight
• Includes health coaching
Wegovy:
• Active ingredient: Semaglutide
• Weekly injection
• £149/month
• Average weight loss: 10-15% of body weight
• Includes health coaching
Key Differences:
1. Effectiveness
• Mounjaro: Dual action on GIP and GLP-1 receptors
• Wegovy: Single action on GLP-1 receptors
• Clinical studies show higher average weight loss with Mounjaro
2. Side Effects
Both medications have similar side effects:
• Nausea (manageable)
• Mild digestive issues
• Decreased appetite
3. Treatment Experience
Both offer:
• Weekly injections
• Easy-to-use pens
• Comprehensive support
• Regular monitoring
Who Should Choose Mounjaro?
• People seeking maximum weight loss potential
• Those who haven't succeeded with other treatments
• Patients with type 2 diabetes
Who Should Choose Wegovy?
• Those preferring an established medication
• People with specific health conditions
• Patients who want a gentler approach
SW Pharma Support Package:
With either medication, you receive:
✓ Initial consultation
✓ Regular check-ins
✓ 24/7 support
✓ Lifestyle guidance
✓ Flexible prescription options
Making Your Decision:
Consider:
1. Your weight loss goals
2. Medical history
3. Lifestyle factors
4. Budget (both same price at SW Pharma)
Next Steps:
Ready to start your weight loss journey? Book a consultation with SW Pharma today. Our medical team will help determine which medication best suits your needs.
Remember: Both medications are effective when combined with lifestyle changes and proper medical supervision.